Friday, July 19, 2024
News
NEWS HOME
»
PRN INDIA
Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
  SocialTwist Tell-a-Friend  
   

GENEVA, May 31, 2023 /PRNewswire/ -- 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular  Treatment (JET) Conference in Tokyo. The objective of this study was to assess the safety and efficacy of SELUTION SLRâ„¢, MedAlliance's novel sirolimus-eluting balloon, for endovascular therapy of de novo and non-stented restenotic lesions in the superficial femoral artery (SFA) and popliteal artery (PA).  

Excellent 12-Month Results from SELUTION SFA Trial Presented at JET

The prospective, multicenter single arm trial has involved 134 patients treated across 13 sites in Japan. The primary endpoint of 12-month primary patency of the target lesion was achieved in 87.9% of patients. There was 97% freedom from TLR; no major amputations or deaths; and a 0.7% rate of thrombosis. These results were achieved despite the presence of challenging patients enrolled in the study.

"These data demonstrate that limus can be as effective as paclitaxel without the associated safety concerns and welcomes a new era for DCB,", said Dr. Osamu Iida, Osaka Police Hospital Cardiovascular Center, Osaka, Japan.

"I loved Dr Iida's comment, 'if limus is as effective as paclitaxel without the safety concerns, why would anyone not use limus?'", commented Jeffrey B. Jump, Chairman and CEO of MedAlliance. "We are pleased to see that the Japanese 12 month data is completely aligned with the FIM done by Prof Zeller 5 years ago. The US IDE SFA study is now enrolling, which will hopefully confirm the same benefit in US patients as we have seen in Europe and Japan."    

SELUTION SLR was awarded CE Mark Approval for the treatment of coronary artery disease in May 2020. MedAlliance was the first drug-eluting balloon (DEB) company to receive FDA Breakthrough Designation status. Currently three IDE clinical studies are evaluating SELUTION SLR in the US: in CLTI patients with BTK disease; SFA/PPA; and coronary ISR. In addition, MedAlliance received IDE approval for de novo coronary artery lesions in January 2023.  This complements the substantial experience that the company has gained with the SELUTION DeNovo and SUCCESS trials in Europe.

MedAlliance's unique DEB technology involves MicroReservoirs which contain a combination of biodegradable polymer intermixed with the anti-restenotic drug sirolimus, applied as a coating on the surface of an angioplasty balloon. These MicroReservoirs provide controlled and sustained release of the drug for up to 90 days. MedAlliance's proprietary CATâ„¢ (Cell Adherent Technology) enables the MicroReservoirs to be coated onto balloons and efficiently transferred to adhere to the vessel lumen when delivered via expansion of the balloon.

SELUTION SLR is commercially available in Europe, Asia, the Middle East, and the Americas (outside USA) and most other countries where the CE Mark is recognized. Over 10,000 units have been used for patient treatments in routine clinical practice or as part of coronary clinical trials. Please contact us if your centre is interested in participating in this study.

Media Contact:

Richard Kenyon  
rkenyon@medalliance.com
+44 7831 569940

About MedAlliance

MedAlliance is a medical technology company which announced a staged acquisition by Cordis in October 2022. It is headquartered in Nyon, Switzerland. MedAlliance specializes in the development of ground-breaking technology and commercialization of advanced drug device combination products for the treatment of coronary and peripheral artery disease. For further information visit: www.medalliance.com

MedAlliance_Logo

Photo: https://mma.prnewswire.com/media/2088103/MedAlliance_JET.jpg
Logo: https://mma.prnewswire.com/media/1196864/MedAlliance_Logo.jpg

Cision View original content:https://www.prnewswire.com/in/news-releases/excellent-12-month-results-from-selution-sfa-trial-presented-at-jet-301837131.html

More News by PR Newswire India

/DISREGARD RELEASE: Bybit/

Kushal's Fashion Jewellery Festive Collection, adorned by Tara Sutaria, beautifully combines glamour and elegance

Unilumin Group Signed an Agreement with Saudi Arabia in the Third Belt and Road Forum for International Cooperation

Transport Corporation of India Ltd. (TCI Group) has been recognized as a Maritime Excellence Achiever at GMIS 2023 by The Ministry of Ports, Shipping & Waterways on 19th October 2023

Bitget Introduces 'Futures Quant' With AI Features

Bitget's Q3 Growth: Second-Highest Market Share Surge and Record High for BGB Holders

HarperCollins Publishers India is proud to announce the publication of SPREADING JOY: How Joyalukkas Became the World's Favourite Jeweller by Joy Alukkas with Thomas Scaria and Nidhi Jain

Go Global or Go Home: New Report Reveals Companies Lacking Global Presence Will Lose Growth Opportunities

MOVIN rolls out the second phase of Electric Vehicles in Bengaluru paving the way for greener deliveries in logistics

Motilal Oswal Financial Services Ltd. (MOFSL) launches #CorporateMushaira, an audio-first campaign for the World Investor Week

UBBF 2023 Intelligent IP Network Summit in Dubai an Impressive Success

Placing Them Right: IBS Path to MBA Career Success

HDFC ERGO reiterates its commitment on making health insurance Accessible, Affordable and Convenient with launch of 6 new products and 2 service upgrades

capSpire expands its global footprint with entry into the Singapore market

GTPL Hathway records its highest quarterly revenues from operation

CCTV+: International reporters experience the romance and vitality of Hangzhou, China

STL expands its Enterprise Networking solution portfolio with Estelan

Mantittude: Skincare for Men encourages men to unleash their inner 'Pataka' this Diwali

The 134th Canton Fair Opened with Optimized Structure and Upgraded Scale

MADAME TUSSAUDS SINGAPORE UNVEILS LIFELIKE FIGURE OF CRICKET ICON VIRAT KOHLI AMIDST ICC MEN'S CRICKET WORLD CUP!

Ugreen unveils power solutions and personal data storage at the Gitex Trade Show in United Arab Emirates.

Meridean Overseas Education Consultants Announces Half-Day Leave to Celebrate India vs. Pakistan Cricket Match

Xinhua Silk Road: Huai'an, UNESCO creative city of gastronomy, explores innovative dev. of food industry via premier regional food expo

Xinhua Silk Road: Fengxin County in E. China's Jiangxi celebrates bountiful harvest of kiwifruit

Casio to Release G-SHOCK Watches with Shining Metallic-Colored Dials

UEG Week 2023 : Babies with a low birthweight four times more likely to develop fatty liver disease in later life

CGTN: Diffusion of tea and its culture along the Silk Road

NEOM announces Leyja, its latest sustainable tourism destination

Expand North Star 2023 kicks off in Dubai gathering game-changing start-ups to accelerate on global stage

World Health Summit kicks off in Berlin

Hexaware Technologies announces new office in Dehradun to bolster its global delivery network

Chinese automotive industry has overtaken to supercars

Participants of the Made in Russia business mission to India held more than 150 negotiations with local importers and distributors

Rummy Passion Raises the Bar: Instant Withdrawals Now Available for All Tiers

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Rajasthan Police arrests Amarjeet Singh ...
UP government enforces ID display for al...
Five lakh lavender plants cultivated in ...
J&K: Fresh batch of pilgrims embark ...
Gonda train accident: SDRF, NDRF teams d...
Uttarakhand: Tanakpur Champawat National...
More...    
 
 Top Stories
Imran Khwaja, Mubashshir Usmani, Ma... 
Pakistan: Defence forces open fire ... 
One step at a time: Disha Patani st... 
Trailer of new web series 'Life Hil... 
MEA says in touch with 50 Indian na... 
Janhvi Kapoor shares interesting de... 
Mark Wood creates history against W... 
"Congress has caused more damage to...